Novelion Therapeutics Announces January 16, 2020 Effective Date for Commencement of Voluntary Liquidation
09. Januar 2020 19:01 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today announced the definitive date for commencement of...
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters
03. Januar 2020 08:25 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Jan. 03, 2020 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today provided updates on the status of the Company’s...
Novelion Therapeutics Provides Update on Effective Date of Liquidation
11. Dezember 2019 07:46 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today announced that a hearing date has not yet been scheduled...
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters
21. November 2019 17:51 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today provided updates on the status of the Company’s...
Novelion Therapeutics Announces Results of 2019 Annual General Meeting of Shareholders
05. November 2019 12:33 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) today announced the results of its 2019 Annual General Meeting...
Novelion Therapeutics Announces New Trading Symbol
09. Oktober 2019 17:57 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (Ticker: NVLNF) (“Novelion” or the “Company”) announced that, effective as of the...
Novelion Therapeutics Announces Nasdaq Delisting
08. Oktober 2019 08:10 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that on October 7, 2019 the...
Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters
03. Oktober 2019 18:21 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) today announced that it has filed its...
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers
25. September 2019 08:25 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that, further to its press...
Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders
11. September 2019 17:50 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that, further to its press...